Sleep Disorders Trial, Recruiting NCT07191119 Sponsor: St. Jude Children's Research Hospital Condition: Sleep Disorders
Back to Sleep Disorders

Sleep Disorders Trial, Recruiting

NCT07191119
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who survived Acute Lymphoblastic Leukemia (ALL), which is a type of blood cancer
  • People already enrolled in a long-term follow-up program called SJLIFE
  • People who were younger than 21 years old when they were diagnosed with ALL
  • People who are between 20 and 50 years old at the time of joining the trial
  • People who score 8 or higher on a standard sleep difficulty questionnaire called the Insomnia Severity Index, confirmed before joining
  • People who have access to home Wi-Fi and a smartphone
  • People who can speak and understand English
  • People who are able and willing to give their consent to participate

Who may not be able to join:

  • People who are unable to understand the details and requirements of the study, as determined by the lead researcher
  • Female participants who are currently pregnant or planning to become pregnant
  • People who have an implanted electrical medical device, such as a pacemaker
  • People who are currently taking medication for thinking or memory difficulties (such as stimulants) or medication prescribed to manage seizures
  • People who have a history of skin irritation or other problems from stimulation of the inner ear
  • People who are currently using a device-based treatment for a sleep disorder, such as a CPAP machine for sleep apnea
  • People with a past history of certain serious health conditions rated above a moderate severity level, including fainting episodes, irregular heart rhythms, blood vessel disease, or coronary artery disease (confirm with trial site for specific severity ratings)
  • People with currently active serious conditions affecting the cranial nerves, nerve pain, stroke, or anyone who has had a seizure within the past year (confirm with trial site for specific severity ratings)
  • People who are currently enrolled in any other research study involving brain or nerve stimulation

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 21 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Justin E Tanner, PhD, St. Jude Children's Research Hospital

Phone: 888-226-4343

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
St. Jude Children's Research Hospital
Registry
ClinicalTrials.gov
Start date
31 March 2026
Est. completion
1 December 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Mean Change in Subjective Sleep Quality; Mean change in clinical insomnia score; Occurrence of side effects; Adherence to intervention; Mean change in Processing Speed (age adjusted z-score); Mean change in Executive Function (age adjusted z-score); Mean change in Simple Attention (age adjusted z-score); Mean change in Reaction Time (age adjusted z-score); Mean change in Sustained Attention (age adjusted z-score); Mean change in Working Memory (age adjusted z-score); Mean change in Complex Attention (age adjusted z-score); Mean change in Cognitive Flexibility (age adjusted z-score); Mean chang...

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov